Evogene Ltd.
EVGN
$1.05
$0.03933.89%
| Weiss Ratings | EVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | EVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | EVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.43 | |||
| Price History | EVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -17.38% | |||
| 30-Day Total Return | -28.13% | |||
| 60-Day Total Return | -34.42% | |||
| 90-Day Total Return | -34.83% | |||
| Year to Date Total Return | -45.91% | |||
| 1-Year Total Return | -85.89% | |||
| 2-Year Total Return | -81.59% | |||
| 3-Year Total Return | -91.11% | |||
| 5-Year Total Return | -90.01% | |||
| 52-Week High % Change | -88.77% | |||
| 52-Week Low % Change | 2.02% | |||
| Price | EVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $9.00 | |||
| 52-Week Low Price | $0.99 | |||
| 52-Week Low Price (Date) | Apr 09, 2025 | |||
| 52-Week High Price (Date) | May 23, 2024 | |||
| Valuation | EVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 6.57M | |||
| Enterprise Value | 9.89M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.00 | |||
| Earnings Per Share Growth | -81.16% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.72 | |||
| Price/Book (Q) | -4.54 | |||
| Enterprise Value/Revenue (TTM) | 3.92 | |||
| Price | $1.05 | |||
| Enterprise Value/EBITDA (TTM) | -0.99 | |||
| Enterprise Value/EBIT | -0.89 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | EVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 6.80M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | EVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 972 8 931 1900 | |||
| Address | -- | |||
| Website | www.evogene.com | |||
| Country | Israel | |||
| Year Founded | 1999 | |||
| Profitability | EVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | EVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | EVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | $0.37 | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | 178.72% | |||
| Earnings Growth (Q YOY) | 99.93% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | 104.81% | |||
| Balance Sheet | EVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 15.31M | |||
| Cash Per Share (Q) | $2.25 | |||
| Total Current Assets (Q) | 21.59M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 14.84M | |||
| Current Ratio (Q) | 1.155 | |||
| Book Value Per Share (Q) | -$0.22 | |||
| Total Assets (Q) | 39.86M | |||
| Total Current Liabilities (Q) | 18.70M | |||
| Total Debt (Q) | 2.50M | |||
| Total Liabilities (Q) | 25.03M | |||
| Total Common Equity (Q) | -1.45M | |||
| Cash Flow | EVGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
